Literature DB >> 2155179

Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack.

R H Daniels1, W A Houston, M M Petersen, J D Williams, B D Williams, B P Morgan.   

Abstract

The effects of non-lethal complement attack on cultured human rheumatoid synovial cells have been investigated by measuring a variety of parameters. Within 3-4 min of initiating non-lethal complement membrane attack there was a rise in reactive oxygen metabolite release from cultured synovial cells, which slowly returned to basal levels over a period of 45 min. The response was dependent on the formation of the complete C5b-9 complex. Prostaglandin E2 was also released during non-lethal attack in a biphasic manner, an early phase of release occurring within the first hour and a second, larger phase commencing at 4 hr and rising to levels of over 1000 ng/10(6) cells at 24 hr, compared to control levels at this time of less than 100 ng/10(6) cells. This response was dependent on the formation of the C5b-8 complex but did not require C9. Removal of extracellular calcium reduced release of prostaglandin E2 to background levels, and inclusion of an inhibitor of protein synthesis abolished the second phase of release but not the first phase. Non-lethal attack caused release of small amounts of leukotriene B4 but no detectable release of tumour necrosis factor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155179      PMCID: PMC1385595     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

Review 1.  Molecular interactions of cells with antibody and complement: influence of metabolic and physical properties of the target on the outcome of humoral immune attack.

Authors:  S H Ohanian; S I Schlager; T Borsos
Journal:  Contemp Top Mol Immunol       Date:  1978

Review 2.  Mechanisms of tissue damage by the membrane attack complex of complement.

Authors:  B P Morgan
Journal:  Complement Inflamm       Date:  1989

3.  Mechanism of cytolysis by complement.

Authors:  M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

4.  Immunoaffinity purification of human complement component C9 using monoclonal antibodies.

Authors:  B P Morgan; R A Daw; K Siddle; J P Luzio; A K Campbell
Journal:  J Immunol Methods       Date:  1983-11-25       Impact factor: 2.303

5.  Size of the transmembrane channels produced by complement proteins C5b-8.

Authors:  L E Ramm; M B Whitlow; M M Mayer
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

6.  The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.

Authors:  E R Podack; W P Kolb; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts.

Authors:  G R Burmester; A Dimitriu-Bona; S J Waters; R J Winchester
Journal:  Scand J Immunol       Date:  1983-01       Impact factor: 3.487

8.  IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures.

Authors:  R M Wernick; P E Lipsky; E Marban-Arcos; J J Maliakkal; D Edelbaum; M Ziff
Journal:  Arthritis Rheum       Date:  1985-07

9.  Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; J E Meats; R G Russell
Journal:  Biochim Biophys Acta       Date:  1984-02-14

10.  Characterization of human complement components C6 and C7.

Authors:  R G Discipio; J Gagnon
Journal:  Mol Immunol       Date:  1982-11       Impact factor: 4.407

View more
  15 in total

1.  Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59.

Authors:  M Mizuno; K Nishikawa; B P Morgan; S Matsuo
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.

Authors:  R H Daniels; B D Williams; B P Morgan
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  Adhesion molecule expression and complement activation in vessel walls in synovial tissue from patients with chronic inflammatory joint disease.

Authors:  O J Mellbye; Y Shen; K Høgåsen; T E Mollnes; O Førre
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

4.  Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane.

Authors:  Y T Konttinen; A Ceponis; S Meri; A Vuorikoski; P Kortekangas; T Sorsa; A Sukura; S Santavirta
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

Review 5.  Complement and periodontitis.

Authors:  George Hajishengallis
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

6.  Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

Authors:  Y Wang; Q Hu; J A Madri; S A Rollins; A Chodera; L A Matis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.

Authors:  D A Oleesky; R H Daniels; B D Williams; N Amos; B P Morgan
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

8.  The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells.

Authors:  I A Rooney; A Davies; D Griffiths; J D Williams; M Davies; S Meri; P J Lachmann; B P Morgan
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

9.  The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells.

Authors:  K S Kilgore; C M Flory; B F Miller; V M Evans; J S Warren
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

10.  Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis.

Authors:  Nicole L Tramontini; Paul J Kuipers; Colleen M Huber; Kerri Murphy; Keith B Naylor; Autumn J Broady; Kenneth S Kilgore
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.